4.7 Article

Immunomodulatory activity of IR700-labelled affibody targeting HER2

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Near-Infrared Photoimmunotherapy of Cancer

Hisataka Kobayashi et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Article Biochemical Research Methods

The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy

Ryuhei Okada et al.

BIOCONJUGATE CHEMISTRY (2019)

Article Oncology

Mechanisms of immune evasion in breast cancer

Joshua P. Bates et al.

BMC CANCER (2018)

Article Oncology

Near-infrared photoimmunotherapy targeting EGFRShedding new light on glioblastoma treatment

Thomas A. Burley et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Editorial Material Immunology

Introduction to checkpoint inhibitors and cancer immunotherapy INTRODUCTION

Arlene H. Sharpe

IMMUNOLOGICAL REVIEWS (2017)

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Review Immunology

Immunogenic cell death in cancer and infectious disease

Lorenzo Galluzzi et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Cell Biology

ROS homeostasis and metabolism: a dangerous liason in cancer cells

E. Panieri et al.

CELL DEATH & DISEASE (2016)

Article Multidisciplinary Sciences

Near-infrared uncaging or photosensitizing dictated by oxygen tension

Erin D. Anderson et al.

NATURE COMMUNICATIONS (2016)

Review Oncology

HER2 aberrations in cancer: Implications for therapy

Min Yan et al.

CANCER TREATMENT REVIEWS (2014)

Article Biochemistry & Molecular Biology

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Abhishek D. Garg et al.

EMBO JOURNAL (2012)

Review Oncology

Treatment of HER2-positive breast cancer: current status and future perspectives

Carlos L. Arteaga et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2012)

Article Medicine, General & Internal

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Sunil Verma et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

Article Biochemistry & Molecular Biology

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

Makoto Mitsunaga et al.

NATURE MEDICINE (2011)

Article Oncology

Guidelines for the welfare and use of animals in cancer research

P. Workman et al.

BRITISH JOURNAL OF CANCER (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules

Gabriela Kramer-Marek et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Review Oncology

Photodynamic therapy and anti-tumour immunity

Ana P. Castano et al.

NATURE REVIEWS CANCER (2006)

Article Biochemistry & Molecular Biology

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

NE Blachèr et al.

PLOS BIOLOGY (2005)

Review Oncology

Necrosis: a specific form of programmed cell death?

SY Proskuryakov et al.

EXPERIMENTAL CELL RESEARCH (2003)